Results from the international silver graft registry for high-risk patients treated with a metallic-silver impregnated vascular graft

Vascular

Volumn 21, Issue 3, 2013, Pages 137-147

  Zegelman, Max ^a   Guenther, Gisela ^a   Waliszewski, Matthias ^b   Pukacki, Fryderyk ^c   Stanisic, Michal Goran ^c   Piquet, Philippe ^d   Passon, Marius ^e   Halloul, Zuhir ^f   Tautenhahn, Jörg ^g   Claeys, Luc ^h   Agostinho, Claudia ^h   Simici, Dragos ⁱ   Doebrich, Dinah ⁱ   Mueller, Carsten ^j   Balzer, Kai ^j  

^a KRANKENHAUS NORDWEST   (Germany)

^b Medical Scientific Affairs   (Germany)

^c POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^d TIMONE HOSPITAL   (France)

^e Diakonie Klinikum Bethesda   (Germany)

^f University Clinic Magdeburg   (Germany)

^g Clinic Magdeburg   (Germany)

^h RUHR UNIVERSITY BOCHUM   (Germany)

ⁱ Sana Klinikum Hof   (Germany)

^j UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

more..

Author keywords

Antimicrobial; Graft; Infection; Silver coated; Vascular

Indexed keywords

AMPICILLIN; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN; POLYESTER; SILVER;

AGED; ARTICLE; BLOOD VESSEL GRAFT; BLOOD VESSEL PROSTHESIS; CHRONIC KIDNEY FAILURE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DOPPLER FLOWMETRY; FEMALE; GRAFT INFECTION; GRAFT PATENCY; GRAFT REJECTION; HIGH RISK POPULATION; HUMAN; INFECTION; INGUINAL REGION; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PNEUMONIA; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; RISK FACTOR; URINARY TRACT INFECTION; VASCULAR ACCESS; VASCULAR SURGERY; WOUND INFECTION;

EID: 84890195404     PISSN: 17085381     EISSN: 1708539X     Source Type: Journal    
DOI: 10.1177/1708538113478773     Document Type: Article

References (21)

1. Zegelman M, Guenther G, Florek HJ, et al. Results from the first in man german pilot study of the silver graft, a vascular graft impregnated with metallic silver. Vascular 2009;17:190-196
2. Ueberrueck T, Zippel R, Tautenhahn J, Gastinger I, Lippert H, Wahlers T. Vascular Graft infection: in vitro and in vivo investigations of a new vascular graft with long-term protection. J Biomed Mater Res B Appl Biomater 2005;74:601-607
3. Ueberrueck T, Meyer L, Zippel R, Nestler G, Wahlers T, Gastinger I. Healing characteristics of a new silver-coated, gelatin impregnated vascular prosthesis in porcine model. Zentralbl Chir 2005;130:71-76
4. Strathmann M, Wingender J. Use of an oxonol dye in combination with confocal laser scanning microscopy to monitor damage of Staphylococcus aureus cells during colonization of silver-coated vascular graft. Int J Antimicrob Agents 2004;24:234-240
5. Jensen LP, Lepäntalo M, Fossdal JE, et al. Dacron or PTFE for above-knee femoropopliteal bypass. a multicenter randomized study. Eur J Vasc Endovasc Surg 2007;34:44-49
6. Post S, Kraus T, Müller-Reinartz U, et al. Dacron vs. polytetrafluoroethylene grafts for femoropopliteal bypass: a prospective randomised multicentre trial. Eur J Vasc Endovasc Surg 2001;22:226-231
7. Pounds LL, Montes-Walters M, Mayhall CG, et al. A changing pattern of infection after major vascular reconstructions. Vasc Endovascular Surg 2005;39:511-7
8. Nicoloff AD, Taylor LM, McLafferty RB, Moneta GL, Porter JM. Patient recovery after infrainguinal bypass grafting for limb salvage. J Vasc Surg 1998;27:256-263
9. Ricco JB, InterGard Silver Study Group. InterGard silver bifurcated graft: features and results of a multicenter clinical study. J Vasc Surg 2006;44:339-346
10. Bandyk DF. Infection in Prosthetic Vascular Grafts. In: Rutherford RB, ed. Vascular Surgery. 5th edn. Philadelphia: WB Saunders Company, 2000:733-751
11. Brothers TE, Robison JG, Elliott BM. Predictors of prosthetic graft infection after infrainguinal bypass. J AmColl Surg 2009;208:557-561
12. Bandyk DF. Vascular surgical site infection: risk factors and preventive measures. Semin Vasc Surg 2008;21:119-123
13. Larena-Avellaneda A, Russmann S, Fein M, Debus ES. Prophylactic use of the silver-acetate-coated graft in arterial occlusive disease: a retrospective, comparative study. J Vasc Surg 2009;50:790-798
14. Engelhardt M, Bruijnen H, Scharmer C, Wohlgemuth WA, Willy C, Wölfle KD. Prospective 2-years follow-up quality of life study after infrageniculate bypass surgery for limb salvage: lasting improvements only in non-diabetic patients. Eur J Vasc Endovasc Surg 2008;36:63-70
15. Arvela E, Söderström M, Albäck A, Aho PS, Tikkanen I, Lepäntalo M. Estimated glomerular filtration rate (eGFR) as a predictor of outcome after infrainguinal bypass in patients with critical limb ischemia. Eur J Vasc Endovasc Surg 2008;36:77-83. Epub March 19 2008
16. Diehm C, Allenberg JR, Pittrow D, et al. German Epidemiological Trial on Ankle Brachial Index Study Group. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation 2009;120:2053-2061
17. Blumenberg RM, Gelfand ML, Dale WA. Perigraft seromas complicating arterial grafts. Surgery 1985;97:194-204
18. Ahn SS, Machleder HI, Gupta R, Moore WS. Perigraft seroma: clinical, histologic, and serologic correlates. Am J Surg 1987;154: 173-178
19. Vollmar JF, Guldner NW, Mohr W, Paes E. Perigraft-reaction after implantation of vascular prostheses. Pathogenesis, clinical picture and treatment. Int Angiol 1987;6:287-293
20. Chung J, Bartelson BB, Hiatt WR, et al. Wound healing and functional outcomes after infrainguinal bypass with reversed saphenous vein for critical limb ischemia. J Vasc 2006;43:1183-1190
21. Bisdas T, Wilhelmi M, Haverich A, Teebken OE. Cryopreserved arterial homografts vs silver-coated Dacron grafts for abdominal aortic infections with intraoperative evidence of microorganisms. J Vasc Surg 2011;53:1274-1281.e4